MNNGF (Baijin Life Science Holdings) Beta: -4338.5692 (As of Jun. 25, 2026)


MNNGF Baijin Life Science Holdings Ltd MNNGF
35 GF Score
Price $0.08
GF Value $0.04
! 6 Warning Signs
View Full Analysis

What is Baijin Life Science Holdings Beta?

Baijin Life Science Holdings MNNGF 35 Beta is -4338.5692 as of Jun. 25, 2026. GuruFocus rates MNNGF with a GF Score™ of 35/100 and a GF Value™ of $0.04. The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Baijin Life Science Holdings's Beta is -4338.5692.


Baijin Life Science Holdings  (OTCPK:MNNGF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Baijin Life Science Holdings Beta Related Terms


Baijin Life Science Holdings Beta Historical Data

* Premium members only.

The historical data trend for Baijin Life Science Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baijin Life Science Holdings Beta Chart

Baijin Life Science Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.26 1.22 -1.73 15,415.00 20,632.83

Baijin Life Science Holdings Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18,118.31 15,415.00 15,029.07 20,632.83 -10,384.84

MNNGF vs TPR: Beta Comparison

For the Luxury Goods subindustry, Baijin Life Science Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baijin Life Science Holdings Beta vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Beta distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's Beta falls into.


MNNGF
35GF Score
Baijin Life Science Holdings Ltd MNNGF
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baijin Life Science Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -4338.5692 mean?
Baijin Life Science Holdings (MNNGF) has a Beta of -4338.5692 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Baijin Life Science Holdings and its competitors.
Is Baijin Life Science Holdings' Beta too high?
Baijin Life Science Holdings' current Beta is -4338.5692. Overall, Baijin Life Science Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Beta compare to TPR?
Baijin Life Science Holdings' Beta of -4338.5692 can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Retail - Cyclical company?
A good Beta depends on the Retail - Cyclical industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Baijin Life Science Holdings and its competitors. Baijin Life Science Holdings's current Beta is -4338.5692. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Beta of -4338.5692. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 87.5% above its estimated fair value. The current Beta is -4338.5692. Baijin Life Science Holdings' overall GF Score™ is 35/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Beta is -4338.5692 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?

Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued. The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.

Key valuation signals for MNNGF:

  • Beta: -4338.5692
  • GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
  • GF Score™: 35/100 with 6 warning signs

No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Baijin Life Science Holdings Business Description

Other Exchanges 01466:Hong Kong
Address 66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
35GF Score

Get the complete analysis for MNNGF

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.04
GF Value